COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …
addition to those faced by the general population, including concerns about higher risks of …
[HTML][HTML] COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly
variable disease severity and a bimodal course characterized by acute respiratory viral …
variable disease severity and a bimodal course characterized by acute respiratory viral …
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician …
M Gianfrancesco, KL Hyrich, S Al-Adely… - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …
understood. The aim was to examine demographic and clinical factors associated with …
[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …
JA Sparks, ZS Wallace, AM Seet… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-
modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis …
modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis …
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …
because of their ability to ameliorate shared immune pathways across immune-mediated …
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider …
Objective While COVID-19 vaccination prevents severe infections, poor immunogenicity in
immunocompromised people threatens vaccine effectiveness. We analysed the clinical …
immunocompromised people threatens vaccine effectiveness. We analysed the clinical …
Association of race and ethnicity with COVID‐19 outcomes in rheumatic disease: data from the COVID‐19 Global Rheumatology Alliance physician registry
MA Gianfrancesco, LA Leykina, Z Izadi… - Arthritis & …, 2021 - Wiley Online Library
Objective Racial/ethnic minorities experience more severe outcomes of coronavirus disease
2019 (COVID‐19) in the general US population. This study was undertaken to examine the …
2019 (COVID‐19) in the general US population. This study was undertaken to examine the …
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases
M Gianfrancesco, J Yazdany… - Current Opinion in …, 2020 - journals.lww.com
Current data suggest that similar to the general population, age, and comorbidities are risk
factors for poorer COVID-19 outcomes in patients with IMID. Additional research is needed …
factors for poorer COVID-19 outcomes in patients with IMID. Additional research is needed …
[HTML][HTML] The association between severe or dead COVID-19 and autoimmune diseases: a systematic review and meta-analysis
Recently, Chen Tao (Doctor) and colleagues published a retrospective study, and
delineated the clinical characteristics of patients with coronavirus disease 2019 (COVID-19) …
delineated the clinical characteristics of patients with coronavirus disease 2019 (COVID-19) …
Considerations for pharmacologic management of rheumatoid arthritis in the COVID-19 era: a narrative review
R Venkat, ZS Wallace, JA Sparks - Current Rheumatology Reports, 2023 - Springer
Abstract Purpose of Review To review the impact of disease-modifying antirheumatic drugs
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …
(DMARDs) on COVID-19 severity and vaccine immunogenicity and to discuss COVID-19 …